Erratum to: Epidemiology for primary brain tumors: a nationwide population-based study (Journal of Neuro-Oncology, (2017), 131, 3, (525-546), 10.1007/s11060-016-2318-3);Epidemiology for primary brain tumors: A nationwide population-based study

Journal of Neuro-Oncology

Volumn 131, Issue 3, 2017, Pages 525-546

  Darlix, Amélie ^a,b   Zouaoui, Sonia ^a,c   Rigau, Valérie ^c   Bessaoud, Faiza ^a   Figarella Branger, Dominique ^d   Mathieu Daudé, Hélène ^a   Trétarre, Brigitte ^a   Bauchet, Fabienne ^a   Duffau, Hugues ^b,c   Taillandier, Luc ^e   Bauchet, Luc ^b,c  

^a CENTRE VAL D AURELLE   (France)

^b Montpellier University Medical Center   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

^d University of the Mediterranean Aix Marseille II   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Brain tumor; Database; Epidemiology; Incidence; Neuro oncology; Neuropathology

Indexed keywords

ACTH SECRETING ADENOMA; ADAMANTINOUS CRANIOPHARYNGIOMA; ADENOMA LACTANT; ADOLESCENT; ADULT; AGED; ANAPLASTIC EPENDYMOMA; ANAPLASTIC GANGLIOGLIOMA; ANAPLASTIC HAEMANGIOPERICYTOMA; ANAPLASTIC MEDULLOBLASTOMA; ANAPLASTIC MENINGIOMA; ANAPLASTIC OLIGOASTROCYTOMA; ANGIOCENTRIC GLIOMA; ANGIOLIPOMA; ANGIOMATOUS MENINGIOMA; ANGIOSARCOMA; ARTICLE; ASTROBLASTOMA; ASTROCYTOMA; ATYPICAL CHOROID PLEXUS PAPILLOMA; ATYPICAL MENINGIOMA; ATYPICAL TERATOID RHABDOID TUMOR; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CELLULAR EPENDYMOMA; CELLULAR SCHWANNOMA; CENTRAL NERVOUS SYSTEM PRIMITIVE NEUROECTOCNS DERMAL TUMOR; CENTRAL NERVOUS SYSTEM GANGLIONEUROBLASTOMA; CENTRAL NERVOUS SYSTEM NEUROBLASTOMA; CENTRAL NERVOUS SYSTEM TUMOR; CEREBELLAR LIPONEUROCYTOMA; CHILD; CHONDROMA; CHONDROSARCOMA; CHORDOID GLIOMA OF THE THIRD VENTRICLE; CHORDOID MENINGIOMA; CHORDOMA; CHORIOCARCINOMA; CHOROID PLEXUS CARCINOMA; CHOROID PLEXUS PAPILLOMA; CHOROID PLEXUS TUMOR; CLEAR CELL EPENDYMOMA; CLEAR CELL MENINGIOMA; CRANIOPHARYNGIOMA; DESMOPLASTIC INFANTILE ASTROCYTOMA; DESMOPLASTIC MEDULLOBLASTOMA; DIFFUSE MELANOCYTOSIS; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; EMBRYONAL CARCINOMA; EPENDYMOBLASTOMA; EPENDYMOMA; EPIDEMIOLOGICAL DATA; EPITHELIOID HEMANGIOENDOTHELIOMA; EPITHELIOID MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; ESTHESIONEUROBLASTOMA; EWING SARCOMA; EXTRAVENTRICULAR NEUROCYTOMA; FEMALE; FIBRILLARY ASTROCYTOMA; FIBROSARCOMA; FIBROUS MENINGIOMA; FRANCE; FSH SECRETING PITUITARY ADENOMA; GANGLIONEUROMA; GEMISTOCYTIC ASTROCYTOMA; GERM CELL TUMOR; GIANT CELL GLIOBLASTOMA; GLIOBLASTOMA; GLIOMA; GLIOMATOSIS CEREBRI; GLIOSARCOMA; GLIOSIS; GRANULAR CELL TUMOR; GRANULOCYTIC SARCOMA; GROWTH HORMONE SECRETING ADENOMA; HEMANGIOBLASTOMA; HEMANGIOMA; HEMANGIOPERICYTOMA; HIBERNOMA; HISTOLOGY; HUMAN; HYPOPHYSIS ADENOMA; IMMATURE GERM CELL TUMOR; INFANT; KAPOSI SARCOMA; LARGE CELL MEDULLOBLASTOMA; LEIOMYOMA; LEIOMYOSARCOMA; LHERMITTE DUCLOS DISEASE; LIPOMA; LIPOSARCOMA; LYMPHOMA; LYMPHOPLASMACYTE RICH MENINGIOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT MENINGIOMA; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MEDULLOBLASTOMA; MELANOCYTOSIS; MELANOMA; MELANOTIC MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MELANOTIC SCHWANNOMA; MENINGEAL MELANOMATOSIS; MENINGIOMA; MENINGOTHELIAL MENINGIOMA; METAPLASTIC MENINGIOMA; MICROCYSTIC MENINGIOMA; MIXED GERM CELL TUMOR; NERVE TUMOR; NEURILEMOMA; NEUROENDOCRINE CARCINOMA; NEUROEPITHELIOMA; NEUROFIBROMA; NEUROFIBROMATOSIS; NEWBORN; NON SECRETING PITUITARY ADENOMA; OLIGOASTROCYTIC TUMOR; OLIGODENDROGLIOMA; OSTEOCHONDROMA; OSTEOMA; OSTEOSARCOMA; PAPILLARY CRANIOPHARYNGIOMA; PAPILLARY EPENDYMOMA; PAPILLARY GLIONEURONAL TUMOR; PAPILLARY MENINGIOMA; PAPILLARY TUMOR OF THE PINEAL REGION; PARAGANGLIOMA; PILOCYTIC ASTROCYTOMA; PILOMYXOID ASTROCYTOMA; PINEAL BODY TUMOR; PINEAL PARENCHYMAL TUMOR OF INTERMEDIATE DIFFERENTIATION; PINEOBLASTOMA; PITUICYTOMA; PLASMACYTOMA; PLEOMORPHIC XANTHOASTROCYTOMA; PLEXIFORM NEUROFIBROMA; PLEXIFORM SCHWANNOMA; PRIMARY TUMOR; PROLACTINOMA; PROTOPLASMIC ASTROCYTOMA; PSAMMOMATOUS MENINGIOMA; RHABDOID MENINGIOMA; RHABDOMYOMA; RHABDOMYOSARCOMA; ROSETTE FORMING GLIONEURONAL TUMOR OF THE FOURTH VENTRICLE; SECRETORY MENINGIOMA; SOLITARY FIBROUS TUMOR; SPINDLE CELL ONCOCYTOMA OF THE ADENOHYPOPHYSIS; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; SUBEPENDYMOMA; TANICYTIC EPENDYMOMA; TERATOMA; THYROTROPIN SECRETING ADENOMA; TRANSITIONAL MENINGIOMA; YOLK SAC TUMOR; BRAIN TUMOR; FACTUAL DATABASE; MIDDLE AGED; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84995478925     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-016-2340-5     Document Type: Erratum

References (37)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109
2. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system. IARC, Lyon
3. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820
4. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008– 2012. Neuro Oncol 17(Suppl 4):iv1–iv62
5. Wöhrer A, Waldhör T, Heinzl H, Hackl M, Feichtinger J, Gru-ber-Mösenbacher U et al (2009) The austrian brain tumour registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol 95(3):401–411
6. Baldi I, Gruber A, Alioum A, Berteaud E, Lebailly P, Huchet A et al (2011) Descriptive epidemiology of CNS tumors in France: results from the Gironde registry for the period 2000–2007. Neuro Oncol 13(12):1370–1378
7. Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J et al (2012) Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer 48(10):1532–1542
8. DeAngelis LM (2001) Brain tumors. N Engl J Med 344(2):114–123
9. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Pineros M et al (2014) Cancer incidence in five continents, vol X. IARC, Lyon
10. Johannesen TB, Angell-Andersen E, Tretli S, Langmark F, Lote K (2004) Trends in incidence of brain and central nervous system tumors in Norway, 1970–1999. Neuroepidemiology 23(3):101–109
11. Klaeboe L, Lonn S, Scheie D, Auvinen A, Christensen HC, Feychting M et al (2005) Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968–1997. Int J Cancer 117(6):996–1001
12. Deltour I, Johansen C, Auvinen A, Feychting M, Klaeboe L, Schüz J (2009) Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974–2003. J Natl Cancer Inst 101(24):1721–1724
13. Arora RS, Alston RD, Eden TO, Estlin EJ, Moran A, Geraci M et al (2010) Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979–2003. Eur J Cancer 46(9):1607–1616
14. Kaatsch P, Rickert CH, Kühl J, Schüz J, Michaelis J (2001) Population-based epidemiologic data on brain tumors in German children. Cancer 92(12):3155–3164
15. McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M et al (2012) Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro Oncol 14(9):1194–1200
16. Desandes E, Guissou S, Chastagner P, Lacour B (2014) Incidence and survival of children with central nervous system primitive tumors in the french national registry of childhood solid tumors. Neuro Oncol 16(7):975–983
17. Ruiz-Tovar M, López-Abente G, Pollán M, Aragonés N, Ardanaz E, Moreo P et al (1999) Brain cancer incidence in the province of Zaragoza and Navarre (Spain): effect of age, period and birth cohort. J Neurol Sci 164(1):93–99
18. Caldarella A, Crocetti E, Paci E (2011) Is the incidence of brain tumors really increasing? A population-based analysis from a cancer registry. J Neurooncol 104(2):589–594
19. Bauchet L, Rigau V, Mathieu-Daudé H, Figarella-Branger D, Hugues D, Palusseau L et al (2007) French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol 84(2):189–199
20. Rigau V, Zouaoui S, Mathieu-Daudé H, Darlix A, Maran A, Trétarre B et al (2011) French brain tumor database: 5-year histological results on 25756 cases. Brain Pathol 21(6):633–644
21. Zouaoui S, Rigau V, Mathieu-Daudé H, Darlix A, Bessaoud F, Fabbro-Peray P et al (2012) French brain tumor database: general results on 40,000 cases, main current applications and future prospects. Neurochirurgie 58(1):4–13
22. Zouaoui S, Darlix A, Rigau V, Mathieu-Daudé H, Bauchet F, Bessaoud F et al (2015) Descriptive epidemiology of 13,038 newly diagnosed and histologically confirmed meningiomas in France: 2006–2010. Neurochirurgie. pii: S0028-3770(15):00073–9.
23. Kleihues P, Cavenee WK (eds) (2000) World health classification of tumors. Tumors of the nervous system. Pathology and genetics. IARC Scientific Publications, Lyon
24. Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Vil-lano JL (2015) Epidemiology of meningiomas post-Public Law 107–206: The Benign Brain Tumor Cancer Registries Amendment Act. Cancer 121(14):2400–2410
25. Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL et al (2015) Alex’s lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16(Suppl 10):x1–x36
26. Selvanathan SK, Hammouche S, Salminen HJ, Jenkinson MD (2011) Outcome and prognostic features in anaplastic gangli-oglioma: analysis of cases from the SEER database. J Neurooncol 105(3):539–545
27. Couce ME, Aker FV, Scheithauer BW (2000) Chordoid menin-gioma: a clinicopathologic study of 42 cases. Am J Surg Pathol 24(7):899–905
28. Di Ieva A, Laiq S, Nejad R, Schmitz EM, Fathalla H, Karam-chandani J et al (2015) Chordoid meningiomas: incidence and clinicopathological features of a case series over 18 years. Neuropathology 35(2):137–147
29. Sonabend AM, Zacharia BE, Goldstein H, Bruce SS, Hershman D, Neugut AI et al (2014) The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis. J Neurosurg 120(2):300–308
30. Smoll NR, Drummond KJ (2012) The incidence of medulloblas-tomas and primitive neurectodermal tumours in adults and children. J Clin Neurosci 19(11):1541–1544
31. Johnston DL, Keene D, Kostova M, Strother D, Lafay-Cousin L, Fryer C et al (2014) Incidence of medulloblastoma in Canadian children. J Neurooncol 120(3):575–579
32. Bauchet L, Mathieu-Daudé H, Fabbro-Peray P, Rigau V, Fabbro M, Chinot O et al (2010) Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol 12(7):725–735
33. Scott JG, Bauchet L, Fraum TJ, Nayak L, Cooper AR, Chao ST et al (2012) Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer 118(22):5595–5600
34. Zouaoui S, Darlix A, Fabbro-Peray P, Mathieu-Daudé H, Rigau V, Fabbro M et al (2014) Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France. Neurosurg Rev 37(3):415–423
35. Darlix A, Zouaoui S, Virion JM, Rigau V, Mathieu-Daudé H, Blonski M et al (2014) Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France. J Neurooncol 120(3):547–555
36. Menei P, Figarella-Branger D, Bauchet L, Loiseau H, Denyset M, Roman T et al (2014) French research infrastructures to develop and validate glioma biomarkers. Neurosurgery 75(2):E195–E196
37. Labreche K, Simeonova I, Kamoun A, Gleize V, Chubb D, Letouzé E et al (2015) TCF12 is mutated in anaplastic oligoden-droglioma. Nat Commun 6:7207